Editas Medicine (EDIT) Research & Development (2015 - 2025)
Editas Medicine (EDIT) posted Research & Development of $19.78 million for Q3 2025, down 58.5% from $47.64 million a year earlier but up 22.2% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Research & Development (2015 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Research & Development at Editas Medicine was $111.16 million, down 49.5% year-over-year; for FY2024, it came in at $199.25 million, up 12.2% from FY2023.
- Annual Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 15.5% (FY2019 to FY2024).
- In prior years, Editas Medicine's Research & Development was $177.65 million in FY2023 (+1.5%), $174.96 million in FY2022 (+22.8%), $142.51 million in FY2021 (-9.8%) and $158 million in FY2020 (+63.1%).
- Quarterly Research & Development has run from a low of $16.18 million in Q2 2025 to a high of $69.56 million in Q4 2023 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last four quarters, with an average decline of 5.2% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2024, with growth of 82.0%; the weakest was Q2 2025, with a decline of 70.2%.
- According to Business Quant data, Research & Development for the three prior quarters was $16.18 million (Q2 2025), $26.59 million (Q1 2025) and $48.61 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Editas Medicine | 234.09 Mn | -477.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 19.78 Mn |
| Jun 30, 2025 | 16.18 Mn |
| Mar 31, 2025 | 26.59 Mn |
| Dec 31, 2024 | 48.61 Mn |
| Sep 30, 2024 | 47.64 Mn |
| Jun 30, 2024 | 54.21 Mn |
| Mar 31, 2024 | 48.79 Mn |
| Dec 31, 2023 | 69.56 Mn |
| Sep 30, 2023 | 40.51 Mn |
| Jun 30, 2023 | 29.78 Mn |
| Mar 31, 2023 | 37.80 Mn |
| Dec 31, 2022 | 52.00 Mn |
| Sep 30, 2022 | 41.33 Mn |
| Jun 30, 2022 | 43.66 Mn |
| Mar 31, 2022 | 37.98 Mn |
| Dec 31, 2021 | 37.55 Mn |
| Sep 30, 2021 | 29.27 Mn |
| Jun 30, 2021 | 33.75 Mn |
| Mar 31, 2021 | 41.94 Mn |
| Dec 31, 2020 | 61.50 Mn |
API Access
Editas Medicine Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();